• 5-amino-1mq
  • 5-amino-1mq

5-amino-1mq

No.10AM
  • Appearance: White/off-white lyophilized powder
  • Purity: ≥98% (HPLC)
  • Grade: Research Use Only (RUO)
  • Packaging: 100iu/vials or Customizable
$0.00
Specification:
5mg
10mg
50mg
  • 5-amino-1mq

Description

What Is 5-amino-1mq?
5-amino-1mq (also known as 5-amino-1-methylquinolinium iodide or NNMTi) is a selective nicotinamide N-methyltransferase (NNMT) inhibitor with the chemical formula C₁₀H₁₁IN₂ and CAS number 42464-96-0. It is a small organic molecule that targets the substrate-binding site of the NNMT enzyme with high specificity, exhibiting an IC₅₀ value of 1.2 μM.

Mechanism of Action

NNMT is an enzyme that plays a key role in NAD+ metabolism by catalyzing the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (MNAM). This process consumes SAM (a critical methyl donor) and reduces the availability of NAM for NAD+ synthesis.


How It Works?

  • Competitive inhibition: It binds to the substrate-binding site of NNMT, preventing NAM from accessing the enzyme
  • Restoring NAD+ levels: By inhibiting NNMT, it increases the availability of NAM for NAD+ biosynthesis, which is essential for energy metabolism, DNA repair, and cellular longevity
  • Modulating metabolism: It reduces lipogenesis (fat formation) in adipocytes (EC₅₀=30μM) and promotes muscle growth and differentiation

Key Features & Benefits

Core Features

1. Selective NNMT Inhibition
  • A small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor (IC₅₀=1.2 μM) with high specificity for the enzyme’s substrate-binding site, avoiding off-target interactions with other metabolic enzymes.
  • Acts via competitive inhibition to block NNMT-mediated methylation of nicotinamide (NAM), directly regulating NAD+ metabolism.
 
2. Metabolic Pathway Modulation
  • Targets NAD+ biosynthesis by preserving NAM (a precursor for NAD+), while reducing consumption of S-adenosylmethionine (SAM), a critical cellular methyl donor.
  • Exhibits dose-dependent regulation of adipocyte lipogenesis (EC₅₀=30μM) and skeletal muscle differentiation, with dual effects on fat and muscle tissue.

3. Preclinical-Stage Profile

  • Unapproved by the FDA and global regulatory bodies for human clinical use; currently classified as a research chemical with well-documented preclinical safety (low toxicity in animal models).
  • Small-molecule structure enables favorable cellular permeability, including potential penetration of the blood-brain barrier for neurological research.

Key Benefits (Preclinical Research Findings)

1. Metabolic Health Improvement
  • Restores cellular NAD+ levels (declining with age and metabolic dysfunction), supporting mitochondrial energy production and DNA repair.
  • Enhances insulin sensitivity and glucose tolerance in animal models, with potential utility for addressing type 2 diabetes and metabolic syndrome.
2. Weight & Fat Management
  • Reduces de novo lipogenesis (fat formation) in adipocytes and decreases fat accumulation in high-fat diet-fed animal models, leading to measurable body weight reduction.

3.Muscle Growth & Physical Performance

  • Promotes muscle differentiation and increases muscle mass in sedentary mice; when combined with exercise, it boosts grip strength by up to 20% in preclinical trials, supporting muscle recovery and functional performance.

4. Anti-Aging Potential

  • Improves mitochondrial function and preserves NAD+ homeostasis, which mitigates cellular damage linked to age-related declines in tissue function and chronic disease risk.

5. Neurological Protection

  • Supports brain NAD+ metabolism via NNMT inhibition, with preclinical data suggesting potential neuroprotective effects against age-related neurodegenerative conditions by safeguarding neuronal energy supply and reducing oxidative stress.


Applications
1.Metabolic Disease Mechanism & Intervention Research
  • Investigating potential interventions for type 2 diabetes and metabolic syndrome by studying its effects on improving insulin sensitivity, restoring glucose tolerance, and regulating systemic NAD+ homeostasis in animal models.
 
2.Weight & Fat Metabolism Research
  • Exploring anti-obesity strategies via preclinical trials on high-fat diet-fed animals, focusing on its ability to inhibit adipocyte lipogenesis and reduce fat accumulation.
3.Muscle Health & Physical Performance Research
  • Studying muscle differentiation, growth, and exercise performance enhancement, particularly its synergistic effect with exercise (e.g., 20% grip strength improvement in sedentary mice) for muscle recovery and functional improvement research.

4.Anti-Aging & Cellular Homeostasis Research

  • Examining cellular aging mechanisms by evaluating its impact on mitochondrial function, DNA repair capacity, and NAD+ level preservation (NAD+ declines with age and links to age-related tissue dysfunction).

5.Neurological Protection Research

  • Exploring neuroprotective potential for age-related neurodegenerative diseases by researching its ability to penetrate the blood-brain barrier and support brain NAD+ metabolism, safeguarding neuronal energy supply and reducing oxidative stress.



Why Choose Us?
  • High-purity peptide synthesis
  • Full quality documentation (COA, HPLC, MS)
  • OEM/ODM private label support
  • Reliable global delivery
  • Stable bulk supply for distributors